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Abstract
Background: Abnormal body mass and related metabolic disorders may affect female reproductive health. The
purpose of the study was to determine the prevalence of underweight, overweight, obesity, lipid and glucose
metabolism disorders, hypertension, and metabolic syndrome, among Polish women of childbearing age.
Methods: One thousand five hundred eighty-eight non-pregnant Polish women of childbearing age (20–49 years)
who participated in the Multi-Centre National Population Health Examination Survey (WOBASZ II study) in
2013–2014, were assigned to 3 age groups: 20–29 years (n = 403), 30–39 years (n = 600) and 40–49 years (n = 585).
Measurements of weight, height, waist circumference, blood pressure, blood lipids, and blood glucose were taken.
For statistical analysis, the Kruskal-Wallis, Chi-Square, and Cohran-Armitage tests were used.
Results: Of the participants, 4.3% were determined to be underweight, 25.2% were overweight, 15% were obese,
and 53.1% had abdominal obesity. With age, the prevalence of both excessive body mass and abdominal obesity
tended to increase, and that of underweight to decrease. Frequency of hypercholesterolemia and
hypertriglyceridemia found in the whole group were 50% and 12.6% respectively, and also tended to rise with age.
Low serum HDL-cholesterol (high density lipoprotein cholesterol) levels were found in 15.1% of the participants.
Prevalence of impaired fasting glucose in the whole group was 8.2% and tended to increase with age. Diabetes
was found in 1.2% of the participants and its prevalence also tended to rise with age, at the borderline of
significance. Frequency of arterial hypertension and metabolic syndrome in the whole group was 15.7% and 14.1%
respectively and both tended to increase with age.
Conclusions: Overweight and obesity, especially of abdominal type, and the related metabolic abnormalities are
common in Polish women of childbearing age. Their prevalence tends to increase with age. Underweight is
relatively common in the youngest age group.
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Background
Metabolic and hormonal disturbances related to both
underweight and excessive body mass may adversely affect
female procreative health. It concerns both decreased ability
to conceive and complications of pregnancy. Low body
mass may lead to ovulatory disorders [1], and to suppressed
fetal development resulting in decreased birthweight [2–4].
Overweight and obesity may also cause ovulatory disorders
and subfecundity [1, 5]. However, contrary to underweight,
excessive body mass is linked to an increased risk of macro-
somia [6, 7].
It should be emphasized that maternal overweight and
obesity are risk factors for gestational diabetes (GDM) and
hypertensive disorders of pregnancy (HDP) [8–10] which
often result in disturbed fetal development. Furthermore,
a woman’s risk of metabolic syndrome and its components
increases with each pregnancy [11, 12].
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In an earlier study carried out in 2011–2012, with 164
women of childbearing age living in Warsaw, we showed
that excessive body mass and related metabolic disorders
were very common and that some of them tended to in-
crease with age, at least at the borderline of significance
[13]. This study aimed to determine the rates of abnor-
mal body mass and related metabolic disorders among
the various age groups of a representative sample of Pol-
ish women of childbearing age.
Methods
The study group consisted of 1588 non-pregnant women of
childbearing age (20–49 years), who in 2013–2014 took
part in the Multi-Centre National Population Health Exam-
ination Survey (WOBASZ II study). The project was imple-
mented by the Institute of Cardiology, together with five of
Poland’s Medical Universities. The study was accepted by
the Bioethics Committee of Institute of Cardiology in
Warsaw. The details concerning the goals, methods, and
organization chart were presented elsewhere [14].
The WOBASZ II survey included a random sample of
inhabitants from all over Poland, aged 20 years and above.
The randomization had two stages. In each of 16 voivod-
ships, 6 communities were drawn: two small (less than
8000 citizens), two medium (8000–40,000 citizens), and
two large (more than 40,000 citizens), plus the voivod-
ship’s capital, provided it had not been sampled as a large
community. Thereafter, 70 males and 70 females were
drawn from each community. Altogether, 15,120 subjects
(including 1557 ineligible persons) were sampled from
108 communities. The sampling frame included all adults
permanently registered in the surveyed communities. The
personal database of the Ministry of the Interior’s Depart-
ment of State Registers (an electronic register known as
PESEL) was used. A total of 6170 respondents throughout
Poland participated in the study, which was 45.5% of the
total sample of available randomized subjects. A wide
range of classical cardiovascular risk factors among the
participants of the WOBASZ II study were estimated,
using a questionnaire, laboratory tests, and anthropomet-
ric measurements. An earlier WOBASZ survey, per-
formed in 2003–2005, was performed using similar
methodology and included 13,545 subjects [15].
In the present study, female subjects were assigned to
three age groups as follows: 20–29 years (n = 403), 30–
39 years (n = 600), and 40–49 years (n = 585). The analysis
included demographic characteristics (marital status,
education, occupational activity, and the net household in-
come per person), tobacco use, basic health data (self-as-
sessment of health status, oral contraception use, number
of children borne, presence of thyroid disease), body mass,
waist circumference, lipid and glucose concentrations,
blood pressure and presence of metabolic syndrome.
Means, standard deviations, and medians were determined
for the Body Mass Index (BMI), waist circumference, and
serum concentrations of total cholesterol (TC), LDL-
cholesterol (low density lipoprotein cholesterol), HDL-
cholesterol and triglycerides (TG), along with systolic and
diastolic blood pressure (SBP and DBP respectively).
Underweight, overweight and obesity were defined accord-
ing to WHO (World Health Organization) criteria [16];
excessive waist circumference was defined according to
both ATP III (Adult Treatment Panel III) [17] and IDF
(International Diabetes Federation) [18] criteria. Hyperchol-
esterolaemia, hypertriglceridaemia (HTG) and low HDL-
cholesterol levels were recognized using criteria adopted by
the European Society of Cardiology [19]. Low HDL-
cholesterol concentrations were also defined according to
the IDF criteria [18]. Abnormal fasting glucose levels were
recognized according to the recommendations of the Polish
Diabetic Society [20], arterial hypertension according to the
ESH/ESC (European Society of Cardiology and European
Society of Hypertension) recommendations from 2013 [21],
and metabolic syndrome (MS) using criteria established by
IDF in 2005 [18].
Laboratory measurements
Laboratory tests were performed in a single location, Diag-
nostyka Central Laboratory at the Institute of Cardiology
in Warsaw, which holds a CDC certificate (the Centre for
Disease Control Lipid Standardization Program, Atlanta,
USA) and the RIQAS (Random International Quality
Assessment Scheme), a European certificate of quality.
Measurements of lipid and glucose concentrations were
performed by means of the Cobas 6000 analyzer, manufac-
tured by Roche, using agents also purchased from the
company. Total cholesterol and triglyceride concentrations
were measured using enzymatic-colorimetric methods;
LDL- and HDL-cholesterol concentrations by uniform col-
orimetric enzymatic methods; and glucose concentration
by the enzymatic method. The details concerning blood
sampling, transport, and methodology of measurements
are described elsewhere [14].
Assessment of hypertension
The blood pressure measurement was performed three
times on the right arm by means of automatic AND UA-
631 devices, which are approved by AAMI (Association
for the Advancement of Medical Instrumentation). To
assess blood pressure value, the average from the second
and third measurements was taken. Hypertension was
defined as systolic blood pressure ≥ 140 mmHg and/or
diastolic blood pressure ≥ 90 mmHg, or if a subject
reported antihypertensive drug treatment.
Statistical analysis
Continuous variables are presented as means ± standard
deviations and medians. Categorical variables are shown as
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frequencies and percentages (%). Significant differences
between age groups were determined by the Kruskal-Wallis
and Chi-Square tests. The significance of trends was
assessed by the Cohran-Armitage test. A two-sided p-value
<0.05 was considered statistically significant. Statistical
analyses were carried out using the SAS for Windows
software package, ver. 9.2.
Results
Table 1 presents data on marital status, education, occupa-
tional activity, net household income per person, and also
the basic health data of the subjects under study in the three
age groups. Older participants were more frequently mar-
ried and occupationally active than the younger subjects. On
the contrary, the younger females were better educated.
Older women declared good or very good health status less
frequently and suffered because of diseases of the thyroid
gland more often than their younger counterparts.
Mean BMI, waist circumference values, and percentages
of women with abnormal body mass and high waist
circumference are shown in Table 2. The first two vari-
ables tended to increase significantly with age. Similarly,
rates of overweight, obesity, and abdominal obesity exhib-
ited a significant trend of rising with age. On the contrary,
Table 1 Basic characteristics of the women under study
Parameter All
n = 1588
Age (years) P value
20–29 n = 403 30–39 n = 600 40–49 n = 585
Marital status:
Married (%) 68.3 35.7 79.8 79.0 <0.0001
Education:
Primary (%) 19.8 3.7 22.7 27.9 <0.0001
Secondary (%) 38.7 43.9 32.2 41.8
Higher (%) 41.5 52.4 45.1 30.3
Occupational activity (%)
Yes 64.0 52.1 65.9 70.1 <0.0001
No 36.0 47.9 34.1 29.9
Net household income p.p. (%)a
≤ 500 PLN 16.5 15.9 17.9 15.4 ns
501–1000 PLN 33.5 31.4 33.0 35.3
1001–2000 PLN 36.9 37.8 36.2 37.0
2001–3000 PLN 10.1 12.0 9.2 9.9
> 3000 PLN 3.0 2.9 3.7 2.4
Smokers (%)b 19.3 17.9 17.4 22.2 ns
Self-assessment of health status (%)
Very good + good 85.7 92.5 91.0 75.6 <0.0001
Average 13.4 7.5 8.7 22.3
Bad + very bad 0.9 0.0 0.3 2.1
Oral contraception (%) 12.7 13.9 16.0 8.0 0.0003
Number of born children
x ± SD 1.51 ± 1.21 0.46 ± 0.73 1.63 ± 1.02 2.07 ± 1.20
Median 2.00 0 2.00 2.00 0.0001
Number of born children
0 (%) 24.01 65.62 13.32 7.36 0.0001
1 (%) 24.85 24.15 28.84 21.19
2 (%) 35.86 8.66 45.19 44.31
3 (%) 10.16 1.31 8.94 17.34
4 and more 5.11 0.26 3.71 9.81
Diseases of the thyroid gland (%) 12.9 9.0 11.5 17.1 0.0005
aincluded only those who answered the question, i.e. 136 subjects
bat least one cigarette per day currently
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rates of underweight (BMI < 18.5 kg/m2) tended to
decrease with age (Fig. 1).
Lipid profile data and rates of lipid abnormalities are
shown in Table 3. Total cholesterol, LDL-cholesterol, and
triglyceride concentrations showed a significant tendency to
rise with age. However, there were no significant differences
in HDL-cholesterol level in the age groups. Prevalence of
hypercholesterolemia (defined both as elevated total and as
LDL-cholesterol) and hypertriglyceridemia tended to
increase significantly with age. There were no significant
differences in the rates of low HDL-cholesterol levels in the
age groups. A tendency to rise with age, at the level of
borderline significance, was only found when low HDL-
cholesterol levels were defined according to IDF criteria.
Rates of glucose metabolism disorders, arterial hyperten-
sion, and MS are presented in Table 4. Both fasting glucose
concentrations and the prevalence of impaired fasting
glucose levels (IFG) tended to rise significantly with age.
Prevalence of diabetes also exhibited a tendency to rise with
age, but without reaching statistical significance (Fig. 2).
Both systolic and diastolic blood pressure values and arterial
hypertension rates showed a significant likelihood to in-
crease with age. The prevalence of MS tended to rise signifi-
cantly with age as well.
Discussion
In the representative sample of Polish women of childbear-
ing age, the prevalence of overweight and obesity, of
abdominal type, and of most of the related metabolic
abnormalities tended to increase significantly with age. Ab-
normal body mass was found in more than 37% of the par-
ticipants in their thirties and more than 53% of those who
were at least 40 years old. Abdominal obesity, recognized
according to the IDF criteria, was present in every third
woman in the youngest age group and almost in two thirds
of women in the oldest. Metabolic syndrome occurred in
almost every fourth female in the oldest group. This could
be related not only to age itself, but also to the larger num-
ber of pregnancies that occurred in this group (Table 1)
and pregnancy-related complications, such as GDM and
HDP. However, we do not have data about the prevalence
of these disorders, which is a limitation of our study.
Meanwhile, underweight occurred in over 8% of the
youngest participants, and its prevalence tended to decrease
with age.
These results are similar to that of our previous study
conducted in females of childbearing age living in
Warsaw in 2011–2012 [13]. However, abdominal obesity
in Warsaw inhabitants was less frequent and the increas-
ing trends of prevalence of metabolic abnormalities with
age were not significant. Only the trends for low HDL-
levels and MS reached the borderline of significance. We
presume that it resulted from a relatively small size of
the sample under study (n = 164).
The overall mean BMI value in the current study was
24.9 ± 5.2 and increased with age, starting at 22.9 kg/m2 in
the youngest group and rising to 26.5 kg/m2 in the oldest.
The previous WOBASZ study [15], conducted in 2003–
Table 2 Anthropometric characteristics in different age groups
Parameter All Age (years) P value P for trend
20–29 30–39 40–49
BMI (kg/m2) n = 1518
x ± SD 24.9 ± 5.2 22.9 ± 4.1 24.7 ± 4.9 26.5 ± 5.6 <0.0001 <0.0001
Median 23.8 22.0 23.6 25.3
BMI (%)
<18.5 kg/m2 4.3 8.4 4.7 1.1 <0.0001 <0.0001
18.5–24.9 kg/m2 55.5 66.0 58.0 45.7 <0.0001
25–29.9 kg/m2 25.2 17.5 24.1 31.5 <0.0001
≥30 kg/m2 15.0 8.1 13.2 21.7 <0.0001
Waist (cm) N = 1564
x ± SD 82.2 ± 12.1 77.3 ± 11.2 82.4 ± 12.1 85.3 ± 11.6 <0.0001 <0.0001
Median 80.0 75.3 80.0 83.0
Waist (%)a
<80 cm 46.9 65.0 46.6 34.8
≥ 80 cm 53.1 35.0 53.4 65.2 <0.0001 <0.0001
Waist (%)b
<88 cm 70.4 82.7 70.2 62.3
≥ 88 cm 29.6 17.3 29.8 37.7 <0.0001 <0.0001
aaccording to the IDF criteria, baccording to the ATP III criteria
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2005, showed similar results in females aged 20–44 years.
However, in the present study, the overall overweight and
obesity rates were much higher, 25.2% vs 19%, and 15% vs
9.6% respectively. Underweight, by contrast, occurred in
women of childbearing age in the same percentage of
participants (about 4%) in both of the WOBASZ studies.
Excessive body mass is thus unequivocally more frequent
in Polish women of childbearing age than underweight and
its prevalence has increased in the last decade.
When compared to American women of childbearing age
who took part in the National Health and Nutrition Exam-
ination Survey (NHANES), conducted from 1999 to 2008,
the participants of our study were much leaner. The mean
BMI of US women aged 16–49 years was 27.7 kg/m2 [22].
Lipid disorders were common in the participants of
our study. Their prevalence was somewhat higher than a
decade ago in females aged 20–44 years. Frequencies
of hypercholesterolemia (defined as LDL-cholesterol
≥3.0 mmol/l), hypertriglyceridemia and low HDL-chol
levels (according to IDF criteria) were 40.6% vs 37%,
12.6% vs 10.7%, and 25.4% vs 22.2% respectively [20].
Also the mean serum glucose level was somewhat higher
than that in the 2003–2005 WOBASZ study, where in
women aged 20–34 and 35–44 years values were
4.4 mmol/l and 4.7 mmol/l respectively. Diabetes was
found in 1.2% of our participants, compared to only
0.5% in the WOBASZ study performed a decade ago
[15]. Over the last ten years, the hypertension rate in
Polish females of childbearing age increased from about
6% to 15.7%. In summary, during the last decade, the
rates of excessive body mass and the related metabolic
disorders increased markedly in the population of Polish
women of childbearing age. However, it is worth
mentioning that an analysis of the WOBASZ data
collected in years 2003 to 2005 showed that physical
activity is an important protective factor against meta-
bolic complications of overweight and obesity in
women of childbearing age [23]. Thus, regular exer-
cise should be encouraged in this population group.
As mentioned in the introduction, excessive body mass
and the related metabolic disorders are a great threat to
procreative health. They may impair fertility, and also
foster development of such pregnancy complications as
HDP and GDM. Besides, they may contribute to fetal
macrosomia and an increased risk of diabetes, arterial
hypertension, lipid disorders and cardiovascular disease in
Fig. 1 Percentages of women with different BMI ranges across age groups
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the child’s adulthood. It should be noted that prevalence
of thyroid disease was also higher in older age groups.
This is of concern because both hypo- and hyperthyroid-
ism may impair fetal development and the course of preg-
nancy [24].
The trends for increased rates of many of the de-
scribed disorders with age is worrying in the light of a
tendency to postpone pregnancy, observed in Poland in
the last decades,. The age range of the highest fertility
rates has shifted since the nineties from the 20–24 year
age group to the 25–29 year age group. Simultaneously,
fertility rates among the 30–34 year age group have in-
creased considerably. The median age of women giving
birth to a child increased from 26 years in 2000 to some-
what above 29 years in 2013, and the age of mothers
giving birth to their first child increased from before
24 years to slightly above 27 years [25].
This tendency to postpone a decision for parenthood,
and the observed trend of increase in rates of excessive
body mass and the related metabolic disorders with age,
as well as the increase in the prevalence of these abnor-
malities in the last decade, may result in an increase in
reproductive disorders. It seems that infertility is more
prevalent now than it was several decades ago. It is esti-
mated that infertility-related problems concern about
19% of couples in Poland [26]. There is no reliable data
about the prevalence of pregnancy complications, such
as GDM and HDP in Poland. It is estimated that gesta-
tional diabetes in various populations occur in 1%–14%
of pregnancies [27]. It was shown recently that its
Table 3 Serum lipid characteristics in different age groups
Parameter All Age (years) P value P for trend
20–29 30–39 40–49
TC (mmol/l) N = 1528
x ± SD 4.90 ± 1.05 4.54 ± 0.97 4.81 ± 1.03 5.23 ± 1.02 <0.0001 <0.0001
Median 4.89 4.51 4.77 5.24
LDL-chol (mmol/l) N = 1528
x ± SD 2.85 ± 0.85 2.53 ± 0.77 2.79 ± 0.82 3.15 ± 0.85 <0.0001 <0.0001
Median 2.78 2.46 2.69 3.13
TG (mmol/l) N = 1527
x ± SD 1.14 ± 0.70 0.99 ± 0.43 1.11 ± 0.79 1.27 ± 0.73 <0.0001 <0.0001
Median 0.98 0.89 0.95 1.09
HDL-chol (mmol/l) N = 1528
x ± SD 1.58 ± 0.42 1.60 ± 0.42 1.58 ± 0.42 1.55 ± 0.41 ns
Median 1.55 1.59 1.54 1.54
TC (%)
TC < 4.9 mmol/l 50.0 65.7 55.6 33.6
TC ≥ 4.9 mmol/la 50.0 34.3 44.4 66.4 <0.0001 <0.0001
LDL-chol (%)
LDL-chol <3.00 mmol/l 59.4 77.3 63.9 42.5
LDL-chol ≥3.00 mmol/la 40.6 22.7 36.1 57.5 <0.0001 <0.0001
TG (%)
< 1.7 mmol/l 87.4 93.8 89.9 80.3
≥ 1.7 mmol/l 12.6 6.2 10.1 19.7 <0.0001 <0.0001
HDL-chol (%)b
HDL-chol <1.16 mmol/l 15.1 14.4 14.4 16.3 ns
HDL-chol ≥1.16 mmol/l 84.9 85.6 85.6 83.7
HDL-chol (%)c
HDL-chol <1.3 mmol/l 25.4 23.4 23.4 28.8 0.0697
HDL-chol ≥1.3 mmol/l 74.6 76.6 76.6 71.2
aor hypolipemic medication during 3 preceding days.
baccording to the criteria of the European Society of Cardiology, c according to the IDF criteria
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prevalence among pregnant women in the US popula-
tion increased from 0.3% in 1979–1980 to 5.8% in 2008–
2010, which was related to the increase in maternal age
and BMI, and was also linked to an increased rate of
stillbirths [28]. Hypertensive disorders of pregnancy in
the United States was observed in about 12% pregnan-
cies [29]. It seems that the HDP rates are tending to in-
crease. It was observed that the prevalence of HDP
among US delivery hospitalizations increased from 67.2
per 1000 deliveries in 1998 to 81.4 per 1000 deliveries in
2006 [30]. It should be emphasized that GDM may lead
to micro- or macrosomia in the newborn, whilst HDP
may lead to intrauterine growth retardation. These preg-
nancy complications are also recognised risk factors for
maternal cardiovascular disease [31].
Macrosomia in newborns is one of the complications
observed in obese mothers. In Poland between 1992 and
2014, the percentage of newborns with high body mass
(i.e. ≥4000 g) increased from 7.7% to 10.4% [32]. How-
ever, this data should be taken with caution, as the defin-
ition of a live birth was altered in 1994. Nonetheless,
high body mass in newborns is common in Poland, lead-
ing to concerns about the risks of complications in later
adult life, such as obesity, type 2 diabetes, arterial hyper-
tension, and cardiovascular disease, as macrosomia is
implicated in the intrauterine programming of these dis-
orders [8, 9].
It should be emphasised that the epidemic of over-
weight and obesity which has been observed in recent
decades, concerns not only women of childbearing age,
but is a rising global phenomenon [33]. One of the
causes may be the intrauterine programming of meta-
bolic risk, which is of particular concern in pregnancies
among obese and diabetic mothers. Therefore, gesta-
tional obesity and diabetes may largely contribute to the
epidemic of obesity in the general population.
Unlike overweight and obesity, underweight is much
less common in the Polish population of females of
childbearing age. However, it is relatively common in the
youngest age group. Being underweight also involves risk
for pregnancy complications, especially for intrauterine
growth retardation. Therefore, prevention efforts should
not be focused exclusively on excessive body mass.
This study is limited by a relatively low response rate
and also by a non-proportional sampling method. How-
ever, additional statistical analyses were performed that
confirmed a similar age distribution between the general
Polish population and the study group, thus indicating
that the WOBASZ II study was indeed representative for
the general Polish population.
Table 4 Glucose metabolism and blood pressure characteristics, and metabolic syndrome prevalence in different age groups
Parameter All Age (years) P value P for trend
20–29 30–39 40–49
Fasting glucose (mmol/l) N = 1529
x ± SD 4.99 ± 0.75 4.82 ± 0.62 4.99 ± 0.89 5.12 ± 0,63 <0.0001 <0.0001
Median 4.93 4.77 4.91 5.07
Fasting glucose (%)
Normal (<5.6 mmol/l) 90.6 95.3 92.5 85.3 <0.0001
IFG (5,6–6,9 mmol/l) 8.2 4.4 6.1 13.1 <0.0001 <0.0001
Diabetes (diagnosed or fasting glucose ≥7 mmol/l) 1.2 0.3 1.4 1.6 0.0713
SBP (mm Hg) N = 1566
x ± SD 118.4 ± 13.6 114.7 ± 10.3 116.4 ± 12.6 123.0 ± 15.2 <0.0001 <0.0001
Median 117.0 114.5 115.0 121.0
DBP (mm Hg)
x ± SD 77.0 ± 10.1 74.0 ± 8.6 76.2 ± 9.8 79.8 ± 10.7 <0.0001 <0.0001
Median 76.5 74.0 76.0 79.0
BP (%)
< 140/90 mmHg 84.3 96.3 87.5 72.8
≥ 140/90 mmHg or medication 15.7 3.7 12.5 27.2 <0.0001 <0.0001
MS (%) according to IDF
Yes 14.1 5.3 10.4 23.8 <0.0001 <0.0001
No 85.9 94.7 89.6 76.2
IFG- impaired fasting glucose
SBP- systolic blood pressure; DBP- diastolic blood pressure; BP- blood pressure
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Conclusions
Overweight and obesity, especially of abdominal type,
and related metabolic abnormalities are common in Pol-
ish women of childbearing age. Their prevalence tends
to increase with age. Rates of these disorders increased
in the last decade. In contrast to excessive body mass,
underweight is the most common in the youngest age
group and its prevalence tends to decrease with age.
There is a need to monitor and treat abnormal body
mass and metabolic disorders in Polish women of child-
bearing age.
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